BMT CTN Protocol 0702

A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Amrita Krishnan, MD (626-256-4673)

            Protocol Co-Chair: George Somlo, MD (626-359-8111)

            Protocol Co-Chair: Ed Stadtmauer, MD (215-662-7910)

            Protocol Officer: Marcelo Pasquini, MD (414-805-0700)

            Protocol Coordinator: Courtney Nelson (301-251-1161)

            Medical Monitor: Shannon Smiley, MD



This study reached its target accrual on November 15, 2013 and is now closed to new patient enrollment.